This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boekelheide, K. Articles by Meistrich, M. L. Search for Related Content PubMed PubMed Citation Articles by Boekelheide, K. Articles by Meistrich, M. L.

Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) Therapy Fails to Protect Nonhuman Primates (Macaca arctoides) From Radiation-Induced Spermatogenic Failure

HEIDI A. SCHOENFELD

CONNIE C. WENG

GUNAPALA SHETTY

JOHN LEITH

MARVIN L. MEISTRICH

From the ^* Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island; Novartis Pharmaceutical Corporation, East Hanover, New Jersey; the Department of Experimental Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; the Departments of Radiation Oncology and ^|| Surgery, Brown University, Providence, Rhode Island; and the ^¶ Oregon National Primate Center, Beaverton, Oregon.

Correspondence to: Dr Kim Boekelheide, Department of Pathology and Laboratory Medicine, Brown University, Box G-E504, Providence, RI 02912 (e-mail: Kim_Boekelheide{at}Brown.edu).

Treatment of men of reproductive age with radiation or alkylating agents often produces prolonged azoospermia. We previously demonstrated that suppression of testosterone (T) with gonadotropin-releasing hormone (GnRH) analogs restored spermatogenesis following atrophy induced by radiation or chemotherapy in rats. This study tested whether GnRH antagonist therapy could reverse radiation-induced testicular injury in primates with a similar protocol. Adult male stump-tailed macaques were given either 6.7 Gy radiation to the testis alone, 6.7 Gy radiation combined with GnRH-antagonist treatment starting on the day of exposure, or daily injections of the GnRH antagonist Cetrorelix for 3 months alone and were monitored for 18 months. Cetrorelix alone produced a 20-40-week fully reversible suppression of serum T, but although spermatogenic recovery was incomplete, 40%-90% of tubules contained differentiating germ cells. Following radiation alone, testis volumes were reduced to approximately 28% and sperm counts to less than 1% of pretreatment values. A biopsy at 18 months after radiation showed that only 3.0% of seminiferous tubule cross sections had germ cells. In irradiated animals that received GnRH antagonist, testis volumes were reduced to 18% of pretreatment volume, and at 18 months, only 1.9% of seminiferous tubule cross sections contained germ cells. Inhibin B values were reduced to 10% and 3% of pretreatment levels in the radiation-only and the radiation plus GnRH antagonist groups, respectively. Species differences exist in the testicular response to radiation, GnRH antagonist therapy, or both, so that rescue protocols that were successful in rodents might not work in primates.

     Key words: Macaque, testis, spermatogenesis

This article has been cited by other articles:

				Z. Zhang, S. Shao, and M. L. Meistrich Irradiated Mouse Testes Efficiently Support Spermatogenesis Derived From Donor Germ Cells of Mice and Rats J Androl, May 1, 2006; 27(3): 365 - 375. [Abstract] [Full Text] [PDF]

				G. Shetty, C. C. Y. Weng, S. J. Meachem, O. U. Bolden-Tiller, Z. Zhang, P. Pakarinen, I. Huhtaniemi, and M. L. Meistrich Both Testosterone and Follicle-Stimulating Hormone Independently Inhibit Spermatogonial Differentiation in Irradiated Rats Endocrinology, January 1, 2006; 147(1): 472 - 482. [Abstract] [Full Text] [PDF]